Acadia Healthcare (NASDAQ:ACHC) Updates Q1 2026 Earnings Guidance
by Teresa Graham · The Cerbat GemAcadia Healthcare (NASDAQ:ACHC – Get Free Report) issued an update on its first quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.250-0.300 for the period, compared to the consensus earnings per share estimate of 0.270. The company issued revenue guidance of $820.0 million-$830.0 million, compared to the consensus revenue estimate of $823.7 million. Acadia Healthcare also updated its FY 2026 guidance to 1.300-1.550 EPS.
Acadia Healthcare Stock Performance
ACHC traded down $0.67 on Thursday, hitting $27.34. The company’s stock had a trading volume of 1,981,907 shares, compared to its average volume of 3,538,870. The company’s 50 day simple moving average is $23.13 and its 200-day simple moving average is $19.08. The firm has a market cap of $2.52 billion, a P/E ratio of -2.24, a price-to-earnings-growth ratio of 9.27 and a beta of 0.71. Acadia Healthcare has a 12 month low of $11.43 and a 12 month high of $28.48. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 1.27.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.03 by $0.04. The company had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. Acadia Healthcare’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same period last year, the firm earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Analysts forecast that Acadia Healthcare will post 1.48 EPS for the current year.
Wall Street Analyst Weigh In
ACHC has been the subject of several analyst reports. Barclays raised their price objective on shares of Acadia Healthcare from $14.00 to $20.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 3rd. Jefferies Financial Group reissued a “hold” rating and issued a $24.50 price target on shares of Acadia Healthcare in a report on Monday. Leerink Partners raised their price target on shares of Acadia Healthcare from $14.00 to $22.00 and gave the company a “market perform” rating in a report on Thursday, February 26th. TD Cowen raised their price target on shares of Acadia Healthcare from $22.00 to $24.00 and gave the company a “buy” rating in a report on Thursday, February 26th. Finally, Guggenheim cut their price target on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a report on Monday, February 23rd. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and a consensus price target of $22.19.
Get Our Latest Analysis on Acadia Healthcare
Institutional Trading of Acadia Healthcare
Hedge funds have recently made changes to their positions in the stock. SummitTX Capital L.P. bought a new stake in shares of Acadia Healthcare during the 4th quarter worth $821,000. Counterpoint Mutual Funds LLC lifted its holdings in shares of Acadia Healthcare by 237.0% during the 4th quarter. Counterpoint Mutual Funds LLC now owns 55,521 shares of the company’s stock worth $788,000 after acquiring an additional 39,044 shares during the last quarter. Orion Porfolio Solutions LLC lifted its holdings in shares of Acadia Healthcare by 68.8% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 31,479 shares of the company’s stock worth $714,000 after acquiring an additional 12,831 shares during the last quarter. Federated Hermes Inc. lifted its holdings in shares of Acadia Healthcare by 1.5% during the 4th quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after acquiring an additional 668 shares during the last quarter. Finally, Corient Private Wealth LLC lifted its holdings in shares of Acadia Healthcare by 55.6% during the 2nd quarter. Corient Private Wealth LLC now owns 19,056 shares of the company’s stock worth $432,000 after acquiring an additional 6,813 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.